The company produced an Ancure Device for abdominal aortic aneurism repair (AAA). The company recently pled guilty to the US Dept of Justice for making false statements and other wrongful conduct.

Among the many wrongs committed, it is alleged the company failed to file 2,628 reports with the FDA during the first 19 months on the market, during which time 12 people died and 57 had to have emergency surgical procedures. The device is in over 19,000 people worldwide.

Please submit a complaint for this possible class action if you had to get a procedure to remove the device or if you wish to represent a close family member who has passed away as a result of this device.

If you feel you qualify for damages or remedies that might be awarded in this possible class action, please contact us immediately.

Enter your name:

Enter your email address:


Please provide any additional information
that will help us evaluate your case
regarding the Ancure Endograft System.

Alternate contact information, including
phone numbers and best times for us to call,
will help us serve you more responsively.